MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)

Project: Research

Project Details

StatusFinished
Effective start/end date15/06/2015 → 28/02/2021

Collaborative partners

  • King's College London (lead)
  • University of Bath
  • Epistem Ltd
  • GSTT Guy's and St Thomas' NHS Foundation Trust
  • Imagen Biotech Ltd
  • Imperial College London
  • Myriad RBM Inc
  • University of Birmingham
  • University of Cambridge
  • University of Leeds
  • University of Liverpool
  • University of Manchester
  • Genentech Inc
  • GlaxoSmithKline USA
  • MedImmune LLC
  • UCB Pharma S.A.
  • UCL University College London

Funding

  • MRC Medical Research Council: £17,000.00
  • MRC Medical Research Council: £513,567.00
  • MRC Medical Research Council: £2,476.66